Table 1.
The IC50 of flavokawain A and tumor suppressor gene status in bladder cancer cell lines
| Cell lines | |||||||
|---|---|---|---|---|---|---|---|
| RT4 | UMUC-3 | T24 | HT1376 | 5637 | TCCSUP | HT1197 | |
| Estimated IC50 (µmol/L) | 20.8 | 17.7 | 16.7 | 14.7 | 13.1 | 10.55 | 7.9 |
| p53 | WT | MT/Exon 4 | MT/Exon 5 | MT/Exon 7 | MT/Exon 8 | MT/Exon 10 | MT/Exon 10 |
| RB | − | + | + | − | − | − | − |
| ARF/p16 | HD/HD | HD/HD | WT/MT | WT/WT | WT/WT | WT/WT | WT/WT |
NOTE: Retinoblastoma gene status implied from the expression of protein localized to the nucleus (+, presence of nuclear expression; −, absence of nuclear expression). Tumor suppressors p14 (ARF) and p16 (INK4A; p16).
Abbreviations: WT, wild-type; MT, mutant allele; RB, retinoblastoma; HD, homozygous deletion.